人工多能性幹細胞（iPSC）の生産市場：プロセス、製品・サービス、用途、最終用途別 世界予測 2024-2032

人工多能性幹細胞（iPSC）生産の世界市場は、再生医療における研究開発イニシアチブの高まりにより、2023年から2032年にかけてCAGR 9.8%で成長します。

研究機関とバイオ医薬品企業との協力関係が強化され、技術的進歩が促進され、iPSCベースの治療応用が加速しています。学術界と産業界の相乗効果が強まるにつれて、個別化医療や再生療法における革新的なソリューションのためにiPSCの潜在能力を活用するための努力が相まって、市場は大幅な成長を遂げると思われます。

例えば、2023年、SCG Therapyはシンガポールに最先端の細胞治療製造施設と研究開発センターを開設しました。最先端の細胞治療製造技術と既製のヒトiPS細胞技術を活用したこの施設は、アジア太平洋、欧州、北米の提携病院に細胞治療製品を供給し、世界市場におけるSCGの能力を高めることを目的としています。今回の移転は、SCGが人工多能性幹細胞製造業界の強化に大きく貢献し、世界の需要に応え、増加する患者のニーズに対応するための生産能力を増強することを意味します。

人工多能性幹細胞生産市場は、最終用途、用途、地域によって細分化されています。

研究・学術機関セグメントは、革新的な研究や治療への応用を目的としたiPSCへの注目の高まりに後押しされ、2032年までに大きな市場基盤を確立すると思われます。研究機関は疾患モデリング、創薬、再生医療研究にiPSC技術を活用しており、市場の成長に大きく貢献しています。幹細胞研究のための共同研究や資金提供の急増に伴い、研究・学術機関セグメントはiPSC生産市場の主要な促進要因として立ちはだかると思われます。

再生医療分野は、様々な病状を治療するための再生治療におけるiPSCの応用が拡大していることから、2032年までに大幅な成長が見られると思われます。再生医療が組織修復や臓器再生の可能性で支持を集める中、iPSCはこうした革新的な治療アプローチを進める上で極めて重要な役割を果たしています。再生医療分野では、iPSCをベースとしたソリューションへの注目が高まっており、市場拡大への重要な貢献者として位置づけられています。

欧州の人工多能性幹細胞生産産業は、生物医学研究への旺盛な投資、有利な規制枠組み、再生医療重視の高まりにより、2023年から2032年にかけて顕著なCAGRを記録すると思われます。欧州諸国は、臨床応用に向けたiPSC技術の進歩に大きなコミットメントを示しており、市場成長を牽引しています。バイオテクノロジーが盛んで戦略的な共同研究が行われている欧州は、iPSC生産のシェア形成に重要な役割を果たすと思われます。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 人工多能性幹細胞生産市場の洞察

• 業界情勢
• 業界への影響要因
  • 促進要因
    • がん罹患率の上昇
    • iPS細胞の大きな治療可能性
    • 創薬・医薬品開発への応用拡大
  • 業界の潜在的リスク＆課題
    • 厳しい規制要件
    • 高い生産コスト
• 成長可能性分析
• 規制状況
• 技術情勢
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• 戦略ダッシュボード

第5章 人工多能性幹細胞生産市場推定・予測：プロセス別 2018-2032年

• 主要動向：プロセス別
• 手動iPSC製造プロセス
• 自動化iPSC作製プロセス

第6章 人工多能性幹細胞作製市場の推定・予測：製品・サービス別 2018-2032年

• 主要動向：製品・サービス別
• 製品
  • 消耗品・キット
  • 器具・装置
  • 自動化プラットフォーム
• サービス

第7章 人工多能性幹細胞生産市場推定・予測：用途別 2018-2032年

• 主要動向：用途別
• 医薬品開発・探索
• 再生医療
• トキシコロジー研究
• その他の用途

第8章 人工多能性幹細胞生産市場推計・予測：最終用途別 2018年～2032年

• 主要動向：最終用途別
• 製薬・バイオテクノロジー企業
• 研究・学術機関
• 受託研究機関

第9章 人工多能性幹細胞生産市場推計・予測：地域別、2018年～2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • その他中東とアフリカ

第10章 企業プロファイル

• Lonza
• Axol Biosciences Ltd.
• Evotec SE
• Hitachi Ltd.
• Merck KGaA
• REPROCELLS, Inc.
• Fate Therapeutics
• Thermo Fisher Scientific, Inc.
• StemCellsFactory III
• Applied StemCells, Inc.
• Creative Biolabs
• Bio-Techne Corporation

Data Tables

• TABLE 1 Market revenue, by process (2023)
• TABLE 2 Market revenue, by product & service (2023)
• TABLE 3 Market revenue, by application (2023)
• TABLE 4 Market revenue, by end-use (2023)
• TABLE 5 Market share, by region (2023)
• TABLE 6 Global induced pluripotent stem cells production market size, by region, 2018 - 2023 (USD Million)
• TABLE 7 Global induced pluripotent stem cells production market size, by region, 2024 - 2032 (USD Million)
• TABLE 8 Global induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 9 Global induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 10 Global induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 11 Global induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 12 Global induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 13 Global induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 14 Global induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 15 Global induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 16 Industry impact forces
• TABLE 17 Manual iPSC production process market, 2018 - 2023 (USD Million)
• TABLE 18 Manual iPSC production process market, 2024 - 2032 (USD Million)
• TABLE 19 Automated iPSC production process market, 2018 - 2023 (USD Million)
• TABLE 20 Automated iPSC production process market, 2024 - 2032 (USD Million)
• TABLE 21 Products market, 2018 - 2023 (USD Million)
• TABLE 22 Products market, 2024 - 2032 (USD Million)
• TABLE 23 Consumables & kits market, 2018 - 2023 (USD Million)
• TABLE 24 Consumables & kits market, 2024 - 2032 (USD Million)
• TABLE 25 Instruments/ devices market, 2018 - 2023 (USD Million)
• TABLE 26 Instruments/ devices market, 2024 - 2032 (USD Million)
• TABLE 27 Automated platforms market, 2018 - 2023 (USD Million)
• TABLE 28 Automated platforms market, 2024 - 2032 (USD Million)
• TABLE 29 Service market, 2018 - 2023 (USD Million)
• TABLE 30 Service market, 2024 - 2032 (USD Million)
• TABLE 31 Drug development & discovery market, 2018 - 2023 (USD Million)
• TABLE 32 Drug development & discovery market, 2024 - 2032 (USD Million)
• TABLE 33 Regenerative medicine market, 2018 - 2023 (USD Million)
• TABLE 34 Regenerative medicine market, 2024 - 2032 (USD Million)
• TABLE 35 Toxicology studies market, 2018 - 2023 (USD Million)
• TABLE 36 Toxicology studies market, 2024 - 2032 (USD Million)
• TABLE 37 Other applications market, 2018 - 2023 (USD Million)
• TABLE 38 Other applications market, 2024 - 2032 (USD Million)
• TABLE 39 Pharmaceutical & biotechnology companies market, 2018 - 2023 (USD Million)
• TABLE 40 Pharmaceutical & biotechnology companies market, 2024 - 2032 (USD Million)
• TABLE 41 Research & academic institutes market, 2018 - 2023 (USD Million)
• TABLE 42 Research & academic institutes market, 2024 - 2032 (USD Million)
• TABLE 43 Contract research organizations market, 2018 - 2023 (USD Million)
• TABLE 44 Contract research organizations market, 2024 - 2032 (USD Million)
• TABLE 45 North America induced pluripotent stem cells production market size, by country, 2018 - 2023 (USD Million)
• TABLE 46 North America induced pluripotent stem cells production market size, by country, 2024 - 2032 (USD Million)
• TABLE 47 North America induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 48 North America induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 49 North America induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 50 North America induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 51 North America induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 52 North America induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 53 North America induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 54 North America induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 55 North America induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 56 North America induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 57 U.S. induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 58 U.S. induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 59 U.S. induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 60 U.S. induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 61 U.S. induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 62 U.S. induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 63 U.S. induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 64 U.S. induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 65 U.S. induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 66 U.S. induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 67 Canada induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 68 Canada induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 69 Canada induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 70 Canada induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 71 Canada induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 72 Canada induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 73 Canada induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 74 Canada induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 75 Canada induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 76 Canada induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 77 Europe induced pluripotent stem cells production market size, by country, 2018 - 2023 (USD Million)
• TABLE 78 Europe induced pluripotent stem cells production market size, by country, 2024 - 2032 (USD Million)
• TABLE 79 Europe induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 80 Europe induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 81 Europe induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 82 Europe induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 83 Europe induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 84 Europe induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 85 Europe induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 86 Europe induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 87 Europe induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 88 Europe induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 89 Germany induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 90 Germany induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 91 Germany induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 92 Germany induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 93 Germany induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 94 Germany induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 95 Germany induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 96 Germany induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 97 Germany induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 98 Germany induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 99 UK induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 100 UK induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 101 UK induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 102 UK induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 103 UK induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 104 UK induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 105 UK induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 106 UK induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 107 UK induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 108 UK induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 109 France induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 110 France induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 111 France induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 112 France induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 113 France induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 114 France induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 115 France induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 116 France induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 117 France induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 118 France induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 119 Spain induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 120 Spain induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 121 Spain induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 122 Spain induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 123 Spain induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 124 Spain induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 125 Spain induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 126 Spain induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million
• TABLE 127 Spain induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 128 Spain induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 129 Italy induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 130 Italy induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 131 Italy induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 132 Italy induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 133 Italy induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 134 Italy induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 135 Italy induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 136 Italy induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 137 Italy induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 138 Italy induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 139 Rest of Europe induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 140 Rest of Europe induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 141 Rest of Europe induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 142 Rest of Europe induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 143 Rest of Europe induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 144 Rest of Europe induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 145 Rest of Europe induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 146 Rest of Europe induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 147 Rest of Europe induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 148 Rest of Europe induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 149 Asia Pacific induced pluripotent stem cells production market size, by country, 2018 - 2023 (USD Million)
• TABLE 150 Asia Pacific induced pluripotent stem cells production market size, by country, 2024 - 2032 (USD Million)
• TABLE 151 Asia Pacific induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 152 Asia Pacific induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 153 Asia Pacific induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 154 Asia Pacific induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 155 Asia Pacific induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 156 Asia Pacific induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 157 Asia Pacific induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 158 Asia Pacific induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 159 Asia Pacific induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 160 Asia Pacific induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 161 China induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 162 China induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 163 China induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 164 China induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 165 China induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 166 China induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 167 China induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 168 China induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 169 China induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 170 China induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 171 Japan induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 172 Japan induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 173 Japan induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 174 Japan induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 175 Japan induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 176 Japan induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 177 Japan induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 178 Japan induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 179 Japan induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 180 Japan induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 181 India induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 182 India induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 183 India induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 184 India induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 185 India induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 186 India induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 187 India induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 188 India induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 189 India induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 190 India induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 191 Australia induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 192 Australia induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 193 Australia induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 194 Australia induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 195 Australia induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 196 Australia induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 197 Australia induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 198 Australia induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 199 Australia induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 200 Australia induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 201 Rest of Asia Pacific induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 202 Rest of Asia Pacific induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 203 Rest of Asia Pacific induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 204 Rest of Asia Pacific induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 205 Rest of Asia Pacific induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 206 Rest of Asia Pacific induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 207 Rest of Asia Pacific induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 208 Rest of Asia Pacific induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 209 Rest of Asia Pacific induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 210 Rest of Asia Pacific induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 211 Latin America induced pluripotent stem cells production market size, by country, 2018 - 2023 (USD Million)
• TABLE 212 Latin America induced pluripotent stem cells production market size, by country, 2024 - 2032 (USD Million)
• TABLE 213 Latin America induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 214 Latin America induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 215 Latin America induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 216 Latin America induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 217 Latin America induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 218 Latin America induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 219 Latin America induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 220 Latin America induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 221 Latin America induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 222 Latin America induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 223 Brazil induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 224 Brazil induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 225 Brazil induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 226 Brazil induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 227 Brazil induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 228 Brazil induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 229 Brazil induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 230 Brazil induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 231 Brazil induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 232 Brazil induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 233 Mexico induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 234 Mexico induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 235 Mexico induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 236 Mexico induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 237 Mexico induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 238 Mexico induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 239 Mexico induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 240 Mexico induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 241 Mexico induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 242 Mexico induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 243 Rest of Latin America induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 244 Rest of Latin America induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 245 Rest of Latin America induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 246 Rest of Latin America induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 247 Rest of Latin America induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 248 Rest of Latin America induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 249 Rest of Latin America induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 250 Rest of Latin America induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 251 Rest of Latin America induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 252 Rest of Latin America induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 253 Middle East & Africa induced pluripotent stem cells production market size, by country, 2018 - 2023 (USD Million)
• TABLE 254 Middle East & Africa induced pluripotent stem cells production market size, by country, 2024 - 2032 (USD Million)
• TABLE 255 Middle East & Africa induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 256 Middle East & Africa induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 257 Middle East & Africa induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 258 Middle East & Africa induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 259 Middle East & Africa induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 260 Middle East & Africa induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 261 Middle East & Africa induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 262 Middle East & Africa induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 263 Middle East & Africa induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 264 Middle East & Africa induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 265 South Africa induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 266 South Africa induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 267 South Africa induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 268 South Africa induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 269 South Africa induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 270 South Africa induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 271 South Africa induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 272 South Africa induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 273 South Africa induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 274 South Africa induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 275 Saudi Arabia induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 276 Saudi Arabia induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 277 Saudi Arabia induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 278 Saudi Arabia induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 279 Saudi Arabia induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 280 Saudi Arabia induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 281 Saudi Arabia induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 282 Saudi Arabia induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million
• TABLE 283 Saudi Arabia induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 284 Saudi Arabia induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)
• TABLE 285 Rest of Middle East & Africa induced pluripotent stem cells production market size, by process, 2018 - 2023 (USD Million)
• TABLE 286 Rest of Middle East & Africa induced pluripotent stem cells production market size, by process, 2024 - 2032 (USD Million)
• TABLE 287 Rest of Middle East & Africa induced pluripotent stem cells production market size, by product & service, 2018 - 2023 (USD Million)
• TABLE 288 Rest of Middle East & Africa induced pluripotent stem cells production market size, by product & service, 2024 - 2032 (USD Million)
• TABLE 289 Rest of Middle East & Africa induced pluripotent stem cells production market size, by products, 2018 - 2023 (USD Million)
• TABLE 290 Rest of Middle East & Africa induced pluripotent stem cells production market size, by products, 2024 - 2032 (USD Million)
• TABLE 291 Rest of Middle East & Africa induced pluripotent stem cells production market size, by application, 2024 - 2032 (USD Million)
• TABLE 292 Rest of Middle East & Africa induced pluripotent stem cells production market size, by application, 2018 - 2023 (USD Million)
• TABLE 293 Rest of Middle East & Africa induced pluripotent stem cells production market size, by end-use, 2018 - 2023 (USD Million)
• TABLE 294 Rest of Middle East & Africa induced pluripotent stem cells production market size, by end-use, 2024 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Induced pluripotent stem cells production industry 360 degree synopsis, 2018 - 2032
• FIG 7 Industry landscape analysis, 2018 - 2032 (USD Million)
• FIG 8 Growth potential analysis, by process
• FIG 9 Growth potential analysis, by product & service
• FIG 10 Growth potential analysis, by application
• FIG 11 Growth potential analysis, by end-use
• FIG 12 Porter's analysis
• FIG 13 PESTEL analysis
• FIG 14 Company matrix analysis, 2023
• FIG 15 Competitive analysis of major market players, 2023
• FIG 16 Competitive positioning matrix, 2023
• FIG 17 Strategic dashboard, 2023

Global Induced Pluripotent Stem Cells Production Market will grow at a 9.8% CAGR between 2023 and 2032, owing to the escalating research and development initiatives in regenerative medicine. Collaborations between research institutions and biopharmaceutical companies are intensifying, fostering technological advancements, and accelerating iPSC-based therapeutic applications. As the synergy between academia and industry strengthens, the market will witness substantial growth, propelled by the combined efforts to harness the potential of iPSCs for innovative solutions in personalized medicine and regenerative therapies.

For instance, in 2023, SCG Therapy inaugurated a state-of-the-art cell therapy manufacturing facility and R&D center in Singapore. Leveraging advanced cell therapy manufacturing and off-the-shelf human-induced pluripotent stem cell (iPSC) technology, the facility aims to supply cell therapy products to partner hospitals across Asia Pacific, Europe, and North America, enhancing SCG's capabilities in the global market. This move marks SCG's significant contribution to strengthening the induced pluripotent stem cells production industry, augmenting production capabilities to meet global demand and address increasing patient needs.

The induced pluripotent stem cells production market is fragmented based on end-use, application, and region.

The research and academic institutes segment will establish a significant market foothold by 2032, fueled by the increasing focus on iPSCs for innovative research and therapeutic applications. Research institutions leverage iPSC technology for disease modeling, drug discovery, and regenerative medicine studies, significantly contributing to the market's growth. With a surge in collaborations and funding for stem cell research, the research and academic institutes segment will stand as a key driver in the iPSC production market.

The regenerative medicine segment will witness a substantial upswing by 2032, attributed to the growing application of iPSCs in regenerative therapies for treating various medical conditions. As regenerative medicine gains traction for its potential in tissue repair and organ regeneration, iPSCs play a pivotal role in advancing these innovative therapeutic approaches. The regenerative medicine sector's increasing focus on iPSC-based solutions will position it as a key contributor to market expansion.

Europe induced pluripotent stem cells production industry will register a notable CAGR during 2023 and 2032 due to its robust investments in biomedical research, favorable regulatory frameworks, and an increasing emphasis on regenerative medicine. European countries exhibit a significant commitment to advancing iPSC technology for clinical applications, driving market growth. With a thriving biotechnology landscape and strategic collaborations, Europe will stand as a key contributor to shaping the share of iPSC production.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Induced pluripotent stem cells production industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Process trends
  • 2.1.4 Product & service trends
  • 2.1.5 Application trends
  • 2.1.6 End-use trends

Chapter 3 Induced Pluripotent Stem Cells Production Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of cancer
    • 3.2.1.2 Significant therapeutic potential of iPSC
    • 3.2.1.3 Increased applications in drug discovery & development
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory requirements
    • 3.2.2.2 High production cost
• 3.3 Growth potential analysis
  • 3.3.1 By process
  • 3.3.2 By product & services
  • 3.3.3 By application
  • 3.3.4 By end-use
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis, 2023
• 4.3 Competitive analysis of major market players, 2023
• 4.4 Competitive positioning matrix, 2023
• 4.5 Strategic dashboard, 2023

Chapter 5 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Process, 2018-2032 (USD Million)

• 5.1 Key trends, by process
• 5.2 Manual iPSC production process
• 5.3 Automated iPSC production process

Chapter 6 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Product & Service, 2018-2032 (USD Million)

• 6.1 Key trends, by product & service
• 6.2 Products
  • 6.2.1 Consumables & kits
  • 6.2.2 Instruments/ devices
  • 6.2.3 Automated platforms
• 6.3 Service

Chapter 7 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Drug development & discovery
• 7.3 Regenerative medicine
• 7.4 Toxicology studies
• 7.5 Other applications

Chapter 8 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)

• 8.1 Key trends, by end-use
• 8.2 Pharmaceutical & biotechnology companies
• 8.3 Research & academic institutes
• 8.4 Contract research organizations

Chapter 9 Induced Pluripotent Stem Cells Production Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

• 10.1 Lonza
• 10.2 Axol Biosciences Ltd.
• 10.3 Evotec SE
• 10.4 Hitachi Ltd.
• 10.5 Merck KGaA
• 10.6 REPROCELLS, Inc.
• 10.7 Fate Therapeutics
• 10.8 Thermo Fisher Scientific, Inc.
• 10.9 StemCellsFactory III
• 10.10 Applied StemCells, Inc.
• 10.11 Creative Biolabs
• 10.12 Bio-Techne Corporation